addressing common underlying mechanisms of allergy. Atopia Therapeutics designs biologic candidates intended to provide sustained benefit by modulating immune tolerance. Clinical and preclinical programs explore how these therapies can reduce inflammation, prevent exacerbations, and improve long‑term disease control. The organization collaborates with scientific and medical partners to translate academic research on allergy and immune regulation into therapeutic products. Atopia Therapeutics also communicates scientific updates and corporate developments through professional networks and digital channels.